Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week

Feed Symbols: TMO

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Earnings
  • News

Thermo Fisher Scientific Q4 Adjusted EPS $5.40 Beats $5.19 Estimate, Sales $11.45B Beat $10.43B Estimate

By Benzinga Newsdesk
Today, 7:02 AM
Thermo Fisher Scientific (NYSE:TMO) reported quarterly earnings of $5.40 per share which beat the analyst consensus estimate of $5.19 by 4.05 percent. This is a 17.43 percent decrease over earnings of $6.54 per share

TMO

Read More
1 minute read
  • Earnings
  • Markets
  • News
  • Pre-Market Outlook
  • Trading Ideas

Meta Platforms, Snap And 3 Stocks To Watch Heading Into Wednesday

By Lisa Levin
Today, 5:05 AM
With US stock futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

HUM

Read More
1 minute read
  • Earnings
  • Markets
  • News
  • Pre-Market Outlook
  • Trading Ideas

Investor Optimism Improves Ahead Of Fed’s Decision

By Lisa Levin
Today, 4:55 AM
The CNN Money Fear and Greed index showed some improvement in overall sentiment among US investors. US stocks closed higher on Tuesday ahead of the much-awaited policy decision from the Federal Reserve.

HUM

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target

Barclays Maintains Overweight on Thermo Fisher Scientific, Raises Price Target to $630

By Benzinga Newsdesk
January 24, 7:25 AM
Barclays analyst Luke Sergott maintains Thermo Fisher Scientific (NYSE:TMO) with a Overweight and raises the price target from $570 to $630.

TMO

Read More
1 minute read
  • Dividends
  • Earnings
  • News

$1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today

By Benzinga Insights
January 11, 1:34 PM
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 15 years by 9.62% on an annualized…

TMO

Read More
2 minute read
  • Analyst Ratings

9 Analysts Have This to Say About Thermo Fisher Scientific

By Benzinga Insights
January 3, 2:00 PM
Thermo Fisher Scientific (NYSE:TMO) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent…

TMO

Read More
1 minute read
  • Dividends
  • Earnings
  • News

Here’s How Much $100 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth Today

By Benzinga Insights
December 28, 5:04 PM
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 10 years by 13.74% on an annualized…

TMO

Read More
4 minute read
  • Options

10 Health Care Stocks Whale Activity In Today’s Session

By Benzinga Insights
December 16, 1:37 PM
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.

ABT

Read More
1 minute read
  • FDA
  • News

FDA Grants Emergency Use Authorization For Thermo Fisher Scientific’s Monkeypox Test

By Michael Horton
December 14, 5:13 PM
-Reuters

TMO

Read More
1 minute read
  • Dividends
  • Earnings
  • News

$1000 Invested In Thermo Fisher Scientific 5 Years Ago Would Be Worth This Much Today

By Benzinga Insights
December 13, 2:34 PM
Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 5 years by 15.77% on an annualized…

TMO

Posts navigation

1 2 … 18 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service